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e.2013.05Abstract Introduction: Postoperative radiotherapy of the parotid gland could be achieved with
various radiotherapy techniques. However they irradiate differently the surrounding organs at risk
(OARs) in particular the cochlea, oral cavity & contralateral parotid causing signiﬁcant increase in
the risk of oral mucositis, xerostomia, and hearing deﬁcits on the irradiated side.
Objectives: The aim of this study was to compare radiation doses received by target volume and
different surrounding OARs using three different parotid irradiation techniques aiming to achieve
the optimum technique which shows adequate target coverage and sparing of surrounding OARs
during postoperative 3DCRT treatment of parotid gland cancer patients.
Methodology: Ten patients diagnosed as having parotid cancer were included in this study. They
were subjected to CT simulation and scans were transferred to the treatment planning system. Tar-
get volumes and contralateral parotid, oral cavity, cochlea, spinal cord, brain stem, eyes, lenses and
optic nerves were contoured. Three plans were done using (a) ipsilateral oblique wedged photonnal conformal radiotherapy;
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380 A. Helal, A. Omarpair, (b) oblique wedged photon pair and direct lateral ﬁeld, and (c) ipsilateral mixed photon elec-
tron beams.
For three plans, the dose volume parameters (DVPs) for target volume and surrounding OARs
were compared and analyzed statistically.
Results: Target dose coverage was adequate and comparable for techniques 1 and 2. Technique 2
showed the best dose homogeneity and conformity and lowest max dose to PTV and to the whole
body and although the dose to OARs was higher compared to technique 1 it was far lower than
OARs tolerance. On the other hand, technique 3 showed unaccepted underdose & dose inhomoge-
neity within the PTV, the highest doses to OARs and the highest PTV max and body max dose.
Conclusion: The ipsilateral oblique wedged photon pair and direct lateral photon ﬁeld technique is
an optimal treatment technique for parotid cancer patients in comparison to other plans.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Alexandria University Faculty of Medicine.1. Introduction
Parotid gland tumors comprise 3% of all head and neck tu-
mors.1 Radiation therapy (RT) combined with surgery is the
main treatment option for patients with adverse pathological
risk factors such as high tumor grade, tumor size more than
4 cm, tumor localization within the deep lobe of the parotid,
positive surgical margins, lymph node involvement, nerve inﬁl-
tration, advanced pathological stage, perineural and perivascu-
lar invasion, soft tissue extension and recurrent tumor
following resection.1,2
Radiation is commonly administered using linear accelera-
tor of 6 MV-energy using three ipsilateral irradiation tech-
niques. The ﬁrst technique involves a pair of oblique wedged
photon beams, the second uses a pair of oblique wedged pho-
ton beams and a direct lateral ﬁeld and the third technique uses
mixed photons and electron beams.1
The treatment volume generally includes the ipsilateral par-
otid bed and the upper neck nodes.1 Presence of regions of dif-
ferent physical and electron densities such as air cavity, dense
bone and soft tissue create internal inhomogeneity. Presence of
this inhomogeneity with an irregular surface of the volume due
to presence of the external ear, both create a heterogeneous
treatment volume and so dose distribution; for example tumor
might be underdosed due to a decrease in the range of electron
beams in the presence of dense bone, and critical structure
might be overdosed due to increased penetration of photon
beams in the presence of an air cavity.1–3
Although post operative radiotherapy improves locore-
gional control, different acute and late radiotherapy-related
toxicities have been described. These include oral mucositis,
xerostomia, dry ear, ear infections, hearing deﬁcits and ipsilat-
eral hearing loss on the irradiated side.1–6 These toxicities
could be related to different factors such as radiotherapy tech-
nique, size of treatment ﬁeld, total dose and dose/fraction.6,7
Choice of radiotherapy technique is the most important
factor that affects toxicities. Various radiotherapy techniques
have been described; the most commonly used one is a pair
of oblique wedged photon beams which produce a low radia-
tion dose to the contra-lateral parotid gland, but have a high
exit dose through the oral cavity, brain-stem, spinal cord,
and the cochlea.3–5 The second most common radiotherapy
technique is ipsilateral two oblique wedged and direct lateral
photon ﬁelds which show the best dose homogeneity and con-
formity but it shows high dose to OARs which is far lower
than OARs tolerance. The third technique is the mixed photon
electron beam which uses a high energy electron beam of12–20 MeV and a low energy photon beam of 6 MV, this tech-
nique is usually associated with high dose to the contra-lateral
parotid gland, skin and mandible, and a more inhomogeneous
tumor dose distribution.4,5
So different radiotherapy techniques should be evaluated
and compared according to which of them produces adequate
target coverage and at the same time reduces the absorbed
dose to surrounding OARs as the cochlea, oral cavity, brain
stem, spinal cord, contralateral parotid and other normal tis-
sues below their tolerance to reduce the occurrence of oral
mucositis, xerostomia, infections, and sensorineural hearing
loss on the irradiated side.8 Based on the published data on
OARs tolerance and occurrence of toxicities; to avoid the
occurrence of xerostomia, the mean dose to contralateral par-
otid should not exceed 24–26 Gy and the mean dose to the oral
cavity also should be around 35 Gy,9 and to avoid sensorineu-
ral hearing loss, the mean cochlear dose should not exceed
40 Gy.10,112. Aim of work
The aim of this study was to compare radiation doses received
by target volume and different surrounding OARs using three
different parotid irradiation techniques aiming to achieve opti-
mum technique which shows adequate target coverage and
sparing of surrounding organs at risk (OARs) during postop-
erative 3DCRT treatment of parotid gland cancer patients.3. Methods
The material of this study included ten patients diagnosed as
having parotid cancer, who underwent superﬁcial parotidec-
tomy and were referred to the Alexandria Clinical Oncology
Department (ACOD), Alexandria faculty of Medicine for
postoperative radiotherapy to the parotid bed. All the patients
had at least one indication for post-operative radiotherapy
(high-grade histology, inadequate surgical margin, presence
of perineural invasion and nodal disease). All patients were
immobilized using individual thermoplastic head masks with
thermoplastic shoulder ﬁxation and had computed tomogra-
phy (CT) simulation (3 mm slice thickness). The CT data were
transferred to the treatment planning system (Precise Elekta).
Target volumes and OARs contouring and dose prescrip-
tion were performed according to the International Commis-
sion on Radiation Units (ICRU) 62 guidelines.12 Planning
target volume (PTV) and surrounding OARs including
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cochlea, spinal cord, brain stem, eyes, lenses and optic nerves
were contoured. For each patient, three plans were done;
Plan 1: ipsilateral pair of oblique wedged 6 MV photon
beams was used; a wedge angle of 35–60 was used. The beam
weight was about 80–100%. No collimation or couch rotation
was used. Because of the superﬁcial position of the parotid
bed, a bolus of 1–1.5 cm thickness was used in both ﬁelds to
improve target coverage in the build up region.
Plan 2: ipsilateral pair of oblique wedged 6 MV photon
beams and direct lateral photon ﬁeld were used; a wedge angle
of 60 was mostly used for oblique ﬁelds. In some patients a
wedge was added to the lateral ﬁeld with a thick end inferior to
compensate for the hot spot producedbyan air gapat the inferior
part of the ﬁeld (caudal). For the lateral ﬁeld, beam weight was
about 50–70%. No collimation or couch rotation was used. A
bolus of 1–1.5 cm thickness was used in all ﬁelds. Gantry angle,
wedge angle, and beamweighting were adjusted for each patient.
Plan 3: ipsilateral mixed photon electron beams were used.
An ipsilateral 6 Mv open photon beam, with 1-1.5cm bolus
was used and 15 Mev electron beam was delivered. Both beams
were equally weighted.
Regarding ﬁeld size; for oblique ﬁelds the smallest ﬁeld size
was 7X9cm and the largest one was 10X16cm (aver-
age=8X11cm). For lateral ﬁeld the smallest ﬁeld size was
8X9cm and the largest one was 13X16cm (aver-
age=11X11cm). Multi-leaf collimators (MLCs) were used to
shape the PTV and to shield the close OARs. For electron
beam, ﬁeld size was deﬁned using 10x10 or 14x 14 applicator
according to the size of PTV and lead cut out was used to
shape the PTV and to shield the close OAR. A dose of 60Table 1 Comparison of the average of DVPs of PTV, contralatera
cochlea, oral cavity DVPs and body max dose irradiated by three
P values for the differences between the plans are also shown.
PTV DVPs Plan 1 Plan 2 Plan 3 Diﬀe
1/2 P
PTV min 94.5 95 80 0.
0.187
PTV max 113 109.5 120 3
0.024
Inhomogeneity (18.5) (14.5) (40%) 22
0.021
OARs DVPs Plan1 Plan 2 Plan 3 Diﬀe
1/2 &
C. Parotid mean 0.7 14 32 95
0.005
Spinal cord max 53 54 74 2
0.878
Brain stem max 33 36 56 8
0.307
Cont. LC mean 1 7 21 86
0.005
Ipsil, C. mean 22 26 53 15
0.283
Oral cavity mean 55 61 61 10
0.074
Body max dose 115 111 119 3
0.011Gy was prescribed to the center of the PTV according to ICRU
for plan 1 & 2 and in plan 3 it was prescribed at D max for
electron beam and at 3-4cm depth for photon beam.
For all plans, isodose distributions and dose volume histo-
grams (DVH) were generated. Plan comparison depends on
dose coverage of PTV, its conformity, dose homogeneity with-
in PTV, body maximum dose and the sparing of OARs. The
coverage of PTV was evaluated using the minimum and max-
imum dose. Dose inhomogeneity percentage within PTV was
calculated for all patients by subtracting the minimum from
the maximum dose of the PTV. Sparing of OARs was assessed
using the mean dose for contralateral parotid, cochlea & oral
cavity & the maximum point dose of the spinal cord, brain
stem, lenses, and optic nerves were also compared.
3.1. Statistical analysis
For all patients, DVPs were recorded. The differences and %
of reduction of the DVPs between the plans were calculated
and analyzed statistically using excel sheet 2003 and SPSS Wil-
coxon signed Rank test (version18).
4. Results
By reviewing the DVPs of the three treatment plans of all pa-
tients, the followings are the results as regards the dose distri-
bution of the PTV and OARs including contralateral parotid,
spinal cord, brain stem, both cochlea, oral cavity, and body
max dose (Table 1 & Figs. 1 and 2):
Table 1 gives the statistical analysis and DVPs for PTV and
OARs comparing the three plans.l parotid, spinal cord, brain stem, contra lateral and ipsi-lateral
different techniques for parotid cancer patients (all are in %).
rences % plan
values
Diﬀerences % plan
1/3 P values
Diﬀerences % plan
2/3 P values
5 15
0.005
16
0.005
6
0.012
9
0.005
54
0.005
64
0.005
rences % plan
P values
Diﬀerences % plan
1/3 & P values
Diﬀerences % plan
2/3 & P values
98
0.005
56
0.005
28
0.021
26.5
0.022
41
0.019
36
0.011
95
0.005
67
0.005
58
0.019
51
0.007
10
0.260
0
1.00
3
0.008
7
0.005
Figure 1 Comparison of dose coverage and conformity within
the PTV of the three plans. PTV coverage is adequate in plan 1 & 2
and underdosed in plan 3. 95% isodose wash (white) well match
the PTV (red) only in plan 2 (most conformal). It also shows both
cochlea in yellow, parotid in blue, spinal cord in green, brain stem
in purple, eyes in light green and optic nerves in light blue.
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PTV coverage (PTV min) is adequate and comparable for both
plans while the maximum dose and dose inhomogeneity are
signiﬁcantly better with plan 2. Regarding OAR sparing, plan
1 shows a reduction of all DVPs compared with plan 2, how-
ever this reduction is insigniﬁcant for some of DVPs. Plan 2
also shows a signiﬁcant reduction of 3% in body max dose.
4.2. Plan 1 & 3
PTV coverage (PTV min), the maximum dose and dose inho-
mogeneity of plan 1 are signiﬁcantly better than plan 3.
Regarding OAR sparing, plan 1 shows a signiﬁcant reduction
of all DVPs compared with plan 3 except for the oral cavity
mean dose which shows insigniﬁcant reduction with plan 1.
Plan 1 also shows a signiﬁcant reduction of 3% in body max
dose.
4.3. Plan 2 & 3
PTV coverage (PTV min), the maximum dose and dose inho-
mogeneity of plan 2 are signiﬁcantly better than plan 3.
Regarding OAR sparing, plan 2 shows a signiﬁcant reductionof all DVPs compared with plan 3 except for the oral cavity
mean dose which was comparable for both plans. Plan 2 also
shows a signiﬁcant reduction of 7% in body max dose.
To summarize, the three techniques were compared regard-
ing target coverage, conformity, dose homogeneity within
PTV, OARs sparing and body max dose. For techniques 1 &
2 the target coverage was adequate and comparable (Fig. 1a
and b). Although the dose to OARs of the technique 1 was
lower compared to technique 2, the plan was not conformal
and shows unaccepted dose inhomogeneity within the PTV
(Fig. 1a) and higher max dose to PTV and to the body.
Technique 2 showed adequate target coverage with the best
dose homogeneity and conformity (95% of the dose com-
pletely covers the PTV and closely matches its shape)
(Fig. 1b) compared to the other two techniques and the lowest
max dose to PTV and to the whole body. Although the dose to
OARs was higher compared to technique 1, it was signiﬁcant
only for contralateral parotid and contralateral cochlea; also
their values were far lower than OARs tolerance.
Technique 3 showed unaccepted underdose & dose inhomo-
geneity within the PTV (Fig. 1c), the highest doses to OARs
and the highest PTV & body max. dose. DVHs for a typical
patient are shown in Fig. 2 and show the differences in irradi-
ation of the PTV and different OARs with the different tech-
niques. As the doses to the eyes, lenses and optic nerves are
very low and comparable for all patients we did not list them
in the table.
5. Discussion
Postoperative radiotherapy using different techniques, radia-
tion sources and beam energies is an effective treatment in pa-
tients with parotid tumors especially when 3D treatment
planning system (TPS) is used. TPS helps in providing an opti-
mal treatment plan for individual patients with more realistic
dose distributions; adequate dose target volume coverage
and sparing of the surrounding OARs.1 This could improve lo-
cal tumor control and reduce the normal organs toxicity there-
by preserving maximum quality of life after radiation therapy.1
In the current study, the resulting isodose distributions of
the three plans showed different degrees of dose coverage,
inhomogeneity, hot spot and the dose to the normal structures;
the mixed electron–photon beam techniques contributed to
lowest dose coverage, highest dose heterogeneity, highest hot
spot and highest OARs doses compared to other photon tech-
niques. The results of the current study are in accordance with
Yaparpalvi et al’s.1 work who performed a dosimetric analysis
of different techniques, among them were the ipsilateral wedge
photon pair, ipsilateral wedge photon pair with a lateral pho-
ton ﬁeld, and the mixed electron–photon beam techniques.
They found that the resulting isodose distributions of the three
plans exhibited different degrees of dose inhomogeneity, hot
spot and the dose to the normal structures; the mixed elec-
tron–photon beam technique contributed to highest dose het-
erogeneity, highest OARs doses compared to other photon
techniques. They explained that the beam obliquity, surface
irregularity, and tissue heterogeneity all modify the beam pen-
etration and depth dose characteristics for electron beams
more than for photon beams.1
In the current study, ipsilateral wedge photon pair with
lateral photon ﬁeld showed adequate target coverage with
Figure 2 Dose volume histograms for PTV (a) contralateral parotid (b), spinal cord (blue) and brain stem (pink) (c) & both cochlea (d)
for a case with parotid cancer planned by three different techniques. The dose is in percentage.
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other two techniques and the lowest max dose to PTV and
to the whole body, although the dose to OARs was higher
compared to the ipsilateral wedge photon pair technique
but it was far lower than OARs tolerance. These results are
also in agreement with Yaparpalvi et al’s.1 work. However
in the current study the hot spot was far lower than they
achieved (115%, 111% & 119% against 120%, 115% &
120–140% in their study) for the three plans respectively.
These differences might be attributed to the difference of
the beam weighting and the difference in the depth of the pre-
scription dose.
Regarding OARs, in both studies, contralateral parotid
mean dose, spinal cord and brain stem max dose were thelowest with the ipsilateral wedge photon pair followed by the
ipsilateral wedge photon pair and lateral ﬁeld and were the
highest with the mixed electron–photon beam technique.
As the available published data were about radiotherapy of
parotid gland use mainly the ipsilateral wedged photon pair we
will use it for comparison with our plans. In the current study,
for PTV dose coverage; the average of minimum dose to PTV
was 57 Gy (94.5%) and the average of maximum dose was
68 Gy (113%). In Nutting et al’s.5 study the min dose to the
PTV was 55 Gy (91%) and the maximum dose was 62.8 Gy
(105%). Compared to plan 2, the average of minimum dose
to PTV was 57 Gy (95%) and the average of maximum
dose was 66 Gy (109.5%), for plan 3, the average of mini-
mum dose to PTV was 48 Gy (80%) and the average of
384 A. Helal, A. Omarmaximum dose was 72 Gy (120%). Nutting et al.5 and Yirmib-
esoglu et al’s.13 studies found the percentage of the dose inho-
mogeneity was 13% & 30% respectively compared to 18.5%,
14.5% & 40% for the three plans in our work respectively.
In the present work using an oblique wedged pair:
The average of the mean dose to the oral cavity was 33 Gy
which is much higher than the mean dose to the oral cavity
(23 Gy) in the study done by Nutting et al.5 (using a wedged
pair).
The mean dose to the contralateral parotid was 0.4 Gy
which is much lower than the mean dose in the study done
by Nutting et al.5 (1.6 ± 0.7 Gy) and Yirmibesoglu et al.13
(2.4 Gy) (both used wedged pair technique).
In spite of the higher radiation dose to the oral cavity
(37 Gy & 37 Gy) and the contralateral parotid gland (8 Gy &
19 Gy) in the current study using plan 2 & 3, our results were
still below the tolerance dose that causes xerostomia, which
was determined by Eisbruch et al.14,15 to be 24–26 Gy to the
contralateral parotid gland, and given by Studer et al.9 to be
35 Gy to spare the oral mucosa.
The mean doses to ipsilateral & contralateral cochlea in the
present study, were (13 Gy & 0.6 Gy,) respectively. These val-
ues were far lower than those achieved by Nutting et al.5 for
the ipsilateral cochlea (42.3 Gy) & by Yirmibesoglu et al.13
for the contralateral cochlea (4.8 Gy).
Although the values of the mean dose to the ipsilateral co-
chlea (Gy16 & 32 Gy) & the contralateral cochlea (4 Gy &
13 Gy) in the present study for plan 2 & 3 were higher than
for plan 1, these values were still under the threshold that cause
sensorineural hearing loss which ranges between 30 Gy and
70 Gy.16,17
In the present work the maximum point dose to the brain
stem was far lower than achieved by Nutting et al.5 (20 Gy
in the present work compared to 27.4 Gy in his study)
Although the max point dose to the brain stem in the pres-
ent study for plan 2 & 3 was higher than that for plan 1 (22 Gy
& 34 Gy) these values were still below its tolerance (54 Gy)
So this study presented the details of dosimetric analysis
among three plans used for postoperative radiotherapy of
the parotid gland, however the impact of radiotherapy tech-
nique-related DVPs on patient outcome and toxicity should
be analyzed in future work.6. Conclusion
Based on dose distributions, this study concluded that the ipsi-
lateral oblique wedged photon pair and direct lateral photon
ﬁeld technique is better in comparison to other techniques
for parotid cancer patients.References
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